USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/13028
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStamati, Adela-
dc.contributor.authorRevenco, Ninel-
dc.date.accessioned2020-11-17T20:26:06Z-
dc.date.available2020-11-17T20:26:06Z-
dc.date.issued2020-10-
dc.identifier.urihttps://stiinta.usmf.md/ro/manifestari-stiintifice/zilele-universitatii-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/13028-
dc.descriptionNicolae Testimitanu State University of Medicine and Pharmacy of the Republic of Moldova, Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova, Ziua internațională a științei pentru pace și dezvoltareen_US
dc.description.abstractIntroduction. Incidence of dilated cardiomyopathy (DCM) in children is 0.57/100,000 / year. The management of pediatric DCM is not similar to adults, the results of the combination of beta-blockers (BB) in the behavior of children with DCM is controversial. Purpose. The effects of beta-blockers (BB) in the clinicalhemodynamic evolution of children with DCM. Material and methods. The prospective analytical study included 48 children (age 3 months-18 years) with DCM, based on anamnestic criteria, clinical and imaging criteria, especially echocardiography (Echo) Depending on the treatment, the patients were divided into 2 groups: I -14 children, conventional and BB; II - 34 children - conventional treatment. Results. Most of the children were young (58%), with a predominance of boys (M F-30/18), with heart failure (HF) II-IV NYHA/Ross. Echo parameters with non-perforable predictive value: Tei index, associated with ejection fraction, size of left ventricle (LVEF, IVS thickness), PAPs and mitral regurgitation (grade of IVM). We have noticed an unfavorable evolution in 6 children, including 4 deaths, of which 3 (8.82%) cases in group II (without BB) (Table 1, fig 1). Conclusions. The Tei index is a predictor of death, depending on age and heart failure. The association of BB in the treatment of DCM in children in the early stages contributes to the clinical and functional improvement of the heart. Adverse effects are rare, requiring correct dose titration.en_US
dc.language.isoenen_US
dc.publisherUniversitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu"en_US
dc.subjectdilated cardiomyopathyen_US
dc.subjectbeta-blockersen_US
dc.subjectprognosisen_US
dc.titleThe impact of beta-blockers in the treatment of children with dilated cardiomyopathyen_US
dc.typeOtheren_US
Appears in Collections:Culegere de postere

Files in This Item:
File Description SizeFormat 
The_impact_of_beta_blockers_in_the_treatment_of_children_with_dilated_cardiomyopathy.pdf551.04 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback